# Managed Healthcare Executive

> Managed Healthcare Executive - Healthcare Publication

- Base URL: https://www.managedhealthcareexecutive.com
- Generated: 2026-07-09T06:04:07.951Z
- Content updates: multiple times daily

## Content Access for AI Agents

This site supports content negotiation for AI/LLM consumption. Request any article URL with an appropriate Accept header to receive structured content instead of HTML.

**Supported content types:**
- `text/markdown` — Clean Markdown with YAML frontmatter
- `text/plain` — Plain text (same as Markdown)
- `text/html` — Default HTML response

**Example request:**
```
curl -H "Accept: text/markdown" https://www.managedhealthcareexecutive.com/view/article-slug
```

**YAML frontmatter schema** (returned with every Markdown response):

| Field | Type | Description |
|-------|------|-------------|
| `title` | string | Article headline |
| `description` | string | Summary/excerpt (max 300 chars) |
| `url` | string | Canonical article URL |
| `canonical_url` | string | Canonical URL if different from `url` |
| `published` | ISO 8601 | Original publication date |
| `modified` | ISO 8601 | Last modification date |
| `authors` | string[] | Author display names |
| `content_type` | string | Content category (e.g., "News", "Clinical") |
| `categories` | string[] | Taxonomy categories |
| `tags` | string[] | SEO tags |
| `image` | string | Featured image URL |
| `publisher` | string | Publication/site name |

**Discovery headers** (included on all responses):
- `Link: <https://www.managedhealthcareexecutive.com/llms.txt>; rel="llms"` — RFC 8288 link to this file
- `X-Llms-Txt: https://www.managedhealthcareexecutive.com/llms.txt` — Explicit discovery header

## Usage Policy

- Robots policy: [https://www.managedhealthcareexecutive.com/robots.txt](https://www.managedhealthcareexecutive.com/robots.txt)
- Cache behavior: responses are cached for ~5 minutes (max-age=300, stale-while-revalidate=329)
- Rate guidance: prefer RSS and sitemap feeds over crawling individual pages
- Attribution: All content © MJH Life Sciences. Include source URLs when citing.

## Content Categories

- [Between the Lines](https://www.managedhealthcareexecutive.com/between-the-lines)
- [Business](https://www.managedhealthcareexecutive.com/business)
- [Clinical](https://www.managedhealthcareexecutive.com/clinical)
- [Commentaries](https://www.managedhealthcareexecutive.com/ commentaries)
- [Contributed](https://www.managedhealthcareexecutive.com/contributed)
- [Discussion](https://www.managedhealthcareexecutive.com/discussion)
- [Emerging Leaders in Healthcare](https://www.managedhealthcareexecutive.com/emerging-leaders-in-healthcare)
- [Formulary Watch](https://www.managedhealthcareexecutive.com/formulary-watch)
- [K-Cast](https://www.managedhealthcareexecutive.com/k-cast)
- [NO ADS](https://www.managedhealthcareexecutive.com/noads)
- [News](https://www.managedhealthcareexecutive.com/news)
- [PBMI Innovators](https://www.managedhealthcareexecutive.com/pbmi-innovators)
- [Population Health Perspectives](https://www.managedhealthcareexecutive.com/population-health-perspectives)
- [Publications](https://www.managedhealthcareexecutive.com/journals)
- [Resources](https://www.managedhealthcareexecutive.com/resources)
- [Sponsored Content](https://www.managedhealthcareexecutive.com/sponsored-content)
- [Sponsored Resources](https://www.managedhealthcareexecutive.com/sponsored-resources)
- [Vaccines: 2023 Year in Review](https://www.managedhealthcareexecutive.com/clinical/vaccines-2023-year-in-review)
- [Video Series](https://www.managedhealthcareexecutive.com/video-series)

## Featured Content

- [The difference between a monoclonal antibody and a vaccine may surprise you ](https://www.managedhealthcareexecutive.com/view/the-difference-between-a-monoclonal-antibody-and-a-vaccine-may-surprise-you): Marc Elia of Invyvid explains the difference between vaccines and monoclonal antibodies. 
- [Chronic care is too hard to navigate. It doesn’t have to be](https://www.managedhealthcareexecutive.com/view/chronic-care-is-too-hard-to-navigate-it-doesn-t-have-to-be): Improving outcomes in chronic conditions will require eliminating friction and creating a connected foundation that supports people continuously.
- [Modernizing Pharmacy Benefit Administration: Addressing Legacy System Friction for Health Plans](https://www.managedhealthcareexecutive.com/view/modernizing-pharmacy-benefit-administration-addressing-legacy-system-friction-for-health-plans): Cloud-based pharmacy benefit administration (PBA) platforms are providing transparency for pharmacies and patients.
- [Make lab monitoring of patents taking isotretinoin less routine, more based on symptoms](https://www.managedhealthcareexecutive.com/view/make-lab-monitoring-of-patents-taking-isotretinoin-less-routine-more-based-on-symptoms): University of Vermont Health dermatologists argue that is wasteful and causes undue worry to routinely test patients taking isotretinion for elevated...
- [Nearly 40% of insulin users pay more than $150 a month](https://www.managedhealthcareexecutive.com/view/nearly-40-of-insulin-users-pay-more-than-150-a-month): An American Diabetes Association survey has found that high insulin costs are straining patients financially, with 1 in 3 cutting groceries. A new Se...
- [Vitiligo is associated with mental heath conditions, other autoimmune diseases](https://www.managedhealthcareexecutive.com/view/vitiligo-is-associated-with-mental-heath-conditions-other-autoimmune-diseases): The findings from a matched cohort study add to the body of evidence that people with vitiligo are likely to contend with other health problems.
- [Centanafadine hits primary and key secondary endpoints in ADHD phase 3b trial](https://www.managedhealthcareexecutive.com/view/centanafadine-hits-primary-and-key-secondary-endpoints-in-adhd-phase-3b-trial): A phase 3b trial found that Otsuka's centanafadine significantly improved both ADHD symptoms and anxiety symptoms in adults with ADHD and comorbid anx...
- [A conversation about vaccines and monoclonal antibodies with Marc Elia, Chairman of Invivyd’s Board of Directors](https://www.managedhealthcareexecutive.com/view/a-conversation-about-vaccines-and-monoclonal-antibodies-with-marc-elia-chairman-of-invivyd-s-board-of-directors): In this interview, Marc Elia argues that monoclonal antibodies like VYD2311 offer a fundamentally different approach to COVID-19 prevention than vacci...
- [New study confirms benefits of GLP-1 drugs in patients with PAD](https://www.managedhealthcareexecutive.com/view/new-study-confirms-benefits-of-glp-1-drugs-in-patients-with-pad): GLP-1 receptor agonists can help reduce inflammation and improve blood vessel function in patients with peripheral artery disease.
- [Neffy’s first year: $72.2m in sales, 10,000 schools and broadening payer access](https://www.managedhealthcareexecutive.com/view/neffy-s-first-year-72-2m-in-sales-10-000-schools-and-broadening-payer-access): United Healthcare, Express Scripts, Cigna, Optum Rx and TRICARE offer Neffy without restriction. Neffy is an epinephrine nasal spray available for ana...

## Feeds and Indexes

- [RSS Feed](https://www.managedhealthcareexecutive.com/rss.xml): Latest articles in XML syndication format
- [Sitemap](https://www.managedhealthcareexecutive.com/sitemap.xml): Complete URL index for all published pages
- [News Sitemap](https://www.managedhealthcareexecutive.com/sitemap-news.xml): Recent articles optimized for news indexing
- [Authors Directory](https://www.managedhealthcareexecutive.com/authors): Browse all contributors and their published work